Nicotine pharmacokinetics of electronic cigarettes: a pooled data analysis from the literature.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jacobson (2021)
Low-temperature (< 200 °C) degradation of electronic nicotine delivery system liquids generates toxic aldehydes.
Nonclinical
Chemical
Analysis
Jaegers (2021)
Socioeconomic differences in the motivation to stop using e-cigarettes and attempts to do so.
Population Clinical
Cessation
ENDS
Jahnel (2020)
association of vaping with decreased vascular endothelial growth factor expression and decreased microvessel density in cutaneous wound healing tissue in rats.
Nonclinical
Safety Effects In Animals
Repeat-dose
Jaleel (2021)
Prevalence and associated Factors of E-Cigarette Use among adolescents in Southeast asia: a Systematic Review.
Population Clinical
Consumer Use
Youth Use & Appeal
Jane Ling (2023)
Social, educational, and psychological health correlates of e-cigarette and combustible cigarette use among adolescents in the US from 2015 to 2021.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Janjua (2023)
Firsthand and Secondhand Exposure Levels of Maltol-Flavored Electronic Nicotine Delivery System Vapors Disrupt amino acid Metabolism.
Individual Clinical
Respiratory Toxicity
Jarrell (2021)
Understanding potential mechanisms of harm: the drivers of electronic cigarette-induced changes in alveolar macrophages, neutrophils, and lung epithelial cells.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jasper (2021)
Effects of nicotine and ThC vapor inhalation administered by an electronic nicotine delivery system (ENDS) in male rats.
Nonclinical
Safety Effects In Animals
Repeat-dose
Javadi-Paydar (2019)
Vapor inhalation of cannabidiol (CBD) in rats.
Nonclinical
Safety Effects In Animals
Repeat-dose
Javadi-Paydar (2019)